• Coca-Cola has snared a 16.7 per cent stake in Monster Beverage.
    Coca-Cola has snared a 16.7 per cent stake in Monster Beverage.
Close×

Monster Beverage has sold a 16.7 per cent stake to Coca-Cola for $US2.15 billion ($2.3 billion), giving the soft drink giant a greater hold on the energy drink market.

As part of the deal, The Coca-Cola Company will become Monster’s preferred distribution partner globally and Monster will become Coca-Cola's exclusive energy play.

Coca-Cola will transfer ownership of its worldwide energy business, including Mother, NOS, Full Throttle, Burn, Play and Power Play, and Relentless, to Monster; and Monster will transfer its non-energy business, including Hansen’s Natural Sodas, Peace Tea, Hubert’s Lemonade and Hansen’s Juice Products, to The Coca-Cola Company.
 
“Our equity investment in Monster is a capital efficient way to bolster our participation in the fast-growing and attractive global energy drinks category," Muhtar Kent, chairman and CEO of Coca-Cola said.
 
Rodney C. Sacks, chairman and CEO of Monster, said the transaction represented a unique opportunity for Monster and its shareholders.

“We gain enhanced access to The Coca-Cola Company’s distribution system, the most powerful and extensive system in the world. At the same time, we become The Coca-Cola Company’s exclusive energy play, with a robust portfolio led by our Monster Energy line and The Coca-Cola Company’s energy brands.

“Our business will be bolstered by The Coca-Cola Company energy brands we will acquire, providing us with complementary energy product offerings in many geographies, as well as access to new channels, including vending and specialty accounts,” Sacks said.

Packaging News

Pact Group will delist from the ASX on Wednesday 16 July, the move being the culmination of executive chair and owner Raphael Geminder’s near two-year bid to take full control of the company.

Packaging is at the heart of Suntory’s bold new chapter in Australia, marked by the opening of its $400 million beverage production facility in Swanbank, Queensland – a site purpose-built to deliver high-speed, high-efficiency bottling, canning and kegging through world-class packaging technology and sustainable design.

Ego Pharmaceuticals has unveiled a bold new chapter in its commitment to local manufacturing, announcing a $156 million, decade-long investment to expand its Victorian operations.